Recent ATNF News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 02:00:11 PM
- 180 Life Sciences Announces Review of Strategic Alternatives • GlobeNewswire Inc. • 11/28/2023 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:30:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 10:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:33:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 09:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 08:18:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 01:00:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 08:00:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 08:00:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 12:30:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 10:30:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 10:28:18 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/30/2023 08:56:42 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/15/2023 09:27:04 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/15/2023 09:26:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 09:00:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 08:31:21 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 09:00:11 PM
- 180 Life Sciences Corp. Announces Closing of $3 Million Public Offering • GlobeNewswire Inc. • 08/14/2023 08:29:27 PM
- 180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering • GlobeNewswire Inc. • 08/10/2023 12:46:21 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/10/2023 04:15:19 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 01:00:24 PM
- 180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake • GlobeNewswire Inc. • 08/07/2023 01:00:00 PM
FEATURED Major Triumph: Music Licensing, Inc. (OTC:SONG) Secures Coveted Royalty Stakes in Masterpieces by Elton John, Miley Cyrus, Lil Wayne, Lil Nas X, XXXTENTACION, & Halsey • Nov 27, 2023 9:00 AM
Swifty Global Secures GLI Certification for New Cutting-Edge B2B Gaming Platform • DRCR • Nov 28, 2023 9:15 AM
Nate's Food Co. Successfully Obtains GACC Registration in China, Paving the Way for Contract Execution on Commodities • NHMD • Nov 28, 2023 8:00 AM
Mass Megawatts Announces LOWEST PRICE GUARANTEE on Solar Project Sales and Further Cost Reductions Using our Patent Pending Technologies • MMMW • Nov 28, 2023 8:00 AM
Branded Legacy Commences Buyback of 1,000,000 Preferred Class D Shares • BLEG • Nov 28, 2023 7:23 AM
Avant Technologies, Inc. Names Technology Industry Veteran Timothy Lantz as New CEO • AVAI • Nov 28, 2023 7:00 AM